相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Ladarixin, an inhibitor of the interleukin-8 receptors CXCR1 and CXCR2, in new-onset type 1 diabetes: A multicentre, randomized, double-blind, placebo-controlled trial
Lorenzo Piemonti et al.
DIABETES OBESITY & METABOLISM (2022)
IL8, Neutrophils, and NETs in a Collusion against Cancer Immunity and Immunotherapy
Alvaro Teijeira et al.
CLINICAL CANCER RESEARCH (2021)
IL-8 promotes the calcification of human aortic valve interstitial cells, which is prevented through antagonizing CXCR1 and CXCR2 receptors
K Dhayni et al.
EUROPEAN HEART JOURNAL (2021)
Role of inflammatory chemokines in hypertension
Tomasz P. Mikolajczyk et al.
PHARMACOLOGY & THERAPEUTICS (2021)
Inhibition of CXCR2 alleviates the development of abdominal aortic aneurysm in Apo E-/- mice
Bo Sun et al.
ACTA CIRURGICA BRASILEIRA (2021)
Chemokine Receptor CXCR-2 Initiates Atrial Fibrillation by Triggering Monocyte Mobilization in Mice
Yun-Long Zhang et al.
HYPERTENSION (2020)
Structural basis of CXC chemokine receptor 2 activation and signalling
Kaiwen Liu et al.
NATURE (2020)
Selective blocking of CXCR2 prevents and reverses atrial fibrillation in spontaneously hypertensive rats
Yun-Long Zhang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
Involvement of CXCL1/CXCR2 During Microglia Activation Following Inflammation-Sensitized Hypoxic-Ischemic Brain Injury in Neonatal Rats
Meray Serdar et al.
FRONTIERS IN NEUROLOGY (2020)
Endothelial cells exposed to phosphate and indoxyl sulphate promote vascular calcification through interleukin-8 secretion
Jeanne Bouabdallah et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2019)
Inhibitory effect of recombinant human CXCL8(3-72)K11R/G31P on atherosclerotic plaques in a mouse model of atherosclerosis
Yuanhua Qin et al.
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2019)
Chemokine signaling axis between endothelial and myeloid cells regulates development of pulmonary hypertension associated with pulmonary fibrosis and hypoxia
Aline C. Oliveira et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2019)
Vascular Inflammation and Oxidative Stress: Major Triggers for Cardiovascular Disease
Sebastian Steven et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2019)
Chronic inhibition of chemokine receptor CXCR2 attenuates cardiac remodeling and dysfunction in spontaneously hypertensive rats
Yun-Long Zhang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2019)
Chemokine (C-X-C motif) receptor 2 blockade by SB265610 inhibited angiotensin II-induced abdominal aortic aneurysm in Apo E-/- mice
Hao Nie et al.
HEART AND VESSELS (2019)
Myeloid-derived Suppressor Cells Are Necessary for Development of Pulmonary Hypertension
Andrew J. Bryant et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2018)
CXCL8 hyper-signaling in the aortic abdominal aneurysm
Vivianne B. C. Kokje et al.
CYTOKINE (2018)
CXCL1-CXCR2 axismediates angiotensin II-induced cardiac hypertrophy and remodelling through regulation ofmonocyte infiltration
Lei Wang et al.
EUROPEAN HEART JOURNAL (2018)
Pharmacokinetics of the Oral Selective CXCR2 Antagonist AZD5069: A Summary of Eight Phase I Studies in Healthy Volunteers
Marie Cullberg et al.
DRUGS IN R&D (2018)
Intravital Microscopic Evaluation of the Effects of a CXCR2 Antagonist in a Model of Liver Ischemia Reperfusion Injury in Mice
Thiago Henrique Caldeira de Oliveira et al.
FRONTIERS IN IMMUNOLOGY (2018)
The extracellular matrix in myocardial injury, repair, and remodeling
Nikolaos G. Frangogiannis
JOURNAL OF CLINICAL INVESTIGATION (2017)
CXCR2 Inhibition - a novel approach to treating CoronAry heart DiseAse (CICADA): study protocol for a randomised controlled trial
Jubin P. Joseph et al.
TRIALS (2017)
Chemokines protect vascular smooth muscle cells from cell death induced by cyclic mechanical stretch
Jing Zhao et al.
SCIENTIFIC REPORTS (2017)
Role of the CXCL8-CXCR1/2 Axis in Cancer and Inflammatory Diseases
Helen Ha et al.
THERANOSTICS (2017)
Targeting inflammation to reduce cardiovascular disease risk: a realistic clinical prospect?
Paul Welsh et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
Genetic and Pharmacologic Inhibition of the Chemokine Receptor CXCR2 Prevents Experimental Hypertension and Vascular Dysfunction
Lei Wang et al.
CIRCULATION (2016)
CXCR2 Antagonist MK-7123 A Phase 2 Proof-of-Concept Trial for Chronic Obstructive Pulmonary Disease
Stephen I. Rennard et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)
The effect of a selective CXCR2 antagonist (AZD5069) on human blood neutrophil count and innate immune functions
Stipo Jurcevic et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2015)
A pilot study on reparixin, a CXCR1/2 antagonist, to assess safety and efficacy in attenuating ischaemia-reperfusion injury and inflammation after on-pump coronary artery bypass graft surgery
P. Opfermann et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2015)
The effects of the CXCR2 antagonist, MK-7123, on bone marrow functions in healthy subjects
Nina Hastrup et al.
CYTOKINE (2015)
ELR-CXC chemokine antagonism is neuroprotective in a rat model of ischemic stroke
Barry J. Connell et al.
NEUROSCIENCE LETTERS (2015)
The safety and tolerability of oral AZD5069, a selective CXCR2 antagonist, in patients with moderate-to-severe COPD
A. M. Kirsten et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2015)
A critical role of CXCR2 PDZ-mediated interactions in endothelial progenitor cell homing and angiogenesis
Yuning Hou et al.
STEM CELL RESEARCH (2015)
Role of Neutrophils in Exacerbation of Brain Injury After Focal Cerebral Ischemia in Hyperlipidemic Mice
Josephine Herz et al.
STROKE (2015)
The CXCR2 Gene Polymorphism Is Associated with Stroke in Patients with Essential Hypertension
Yanina R. Timasheva et al.
CEREBROVASCULAR DISEASES EXTRA (2015)
Pharmacological Characterization of AZD5069, a Slowly Reversible CXC Chemokine Receptor 2 Antagonist
David J. Nicholls et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2015)
The CXCL8/IL-8 chemokine family and its receptors in inflammatory diseases
Remo C. Russo et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2014)
G Protein-Coupled Receptor Kinase-6 Interacts with Activator of G Protein Signaling-3 To Regulate CXCR2-Mediated Cellular Functions
Vandana Singh et al.
JOURNAL OF IMMUNOLOGY (2014)
Rare and low-frequency coding variants in CXCR2 and other genes are associated with hematological traits
Paul L. Auer et al.
NATURE GENETICS (2014)
International Union of Pharmacology. LXXXIX. Update on the Extended Family of Chemokine Receptors and Introducing a New Nomenclature for Atypical Chemokine Receptors
Francoise Bachelerie et al.
PHARMACOLOGICAL REVIEWS (2014)
Blockade of CXCR1/2 chemokine receptors protects against brain damage in ischemic stroke in mice
Larissa Fonseca da Cunha Sousa et al.
CLINICS (2013)
Distinct functions of chemokine receptor axes in the atherogenic mobilization and recruitment of classical monocytes
Oliver Soehnlein et al.
EMBO MOLECULAR MEDICINE (2013)
Neutrophil cell surface receptors and their intracellular signal transduction pathways
Krisztina Futosi et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2013)
Biased Agonism as a Mechanism for Differential Signaling by Chemokine Receptors
Sudarshan Rajagopal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
CXC chemokine KC fails to induce neutrophil infiltration and neoangiogenesis in a mouse model of myocardial infarction
Hasan Oral et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2013)
Receptor binding mode and pharmacological characterization of a potent and selective dual CXCR1/CXCR2 non-competitive allosteric inhibitor
R. Bertini et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Safety and efficacy of a CXCR2 antagonist in patients with severe asthma and sputum neutrophils: a randomized, placebo-controlled clinical trial
P. Nair et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2012)
The Chemokine Receptors CXCR1 and CXCR2 Couple to Distinct G Protein-Coupled Receptor Kinases To Mediate and Regulate Leukocyte Functions
Sandeep K. Raghuwanshi et al.
JOURNAL OF IMMUNOLOGY (2012)
Activation of Aryl Hydrocarbon Receptor Induces Vascular Inflammation and Promotes Atherosclerosis in Apolipoprotein E-/- Mice
Dalei Wu et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Reparixin, an Inhibitor of CXCR1 and CXCR2 Receptor Activation, Attenuates Blood Pressure and Hypertension-Related Mediators Expression in Spontaneously Hypertensive Rats
Hye Young Kim et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2011)
Attenuation of leukocyte recruitment via CXCR1/2 inhibition stops the progression of PAH in mice with genetic ablation of endothelial BMPR-II
Victoria J. Burton et al.
BLOOD (2011)
Chemokine-related gene expression in the brain following ischernic stroke: No role for CXCR2 in outcome
Vanessa H. Brait et al.
BRAIN RESEARCH (2011)
CXCR1 and CXCR2 are novel mechano-sensors mediating laminar shear stress-induced endothelial cell migration
Ye Zeng et al.
CYTOKINE (2011)
CXC Chemokine Receptor-1 is Expressed by Hepatocytes and Regulates Liver Recovery After Hepatic Ischemia/Reperfusion Injury
Callisia Clarke et al.
HEPATOLOGY (2011)
CXCR1 and CXCR2 silencing modulates CXCL8-dependent endothelial cell proliferation, migration and capillary-like structure formation
Seema Singh et al.
MICROVASCULAR RESEARCH (2011)
Hyperlipidemia-Triggered Neutrophilia Promotes Early Atherosclerosis
Maik Drechsler et al.
CIRCULATION (2010)
A Novel ELR-CXC Chemokine Antagonist Reduces Intestinal Ischemia Reperfusion-Induced Mortality, and Local and Remote Organ Injury
Xixing Zhao et al.
JOURNAL OF SURGICAL RESEARCH (2010)
Beyond Desensitization: Physiological Relevance of Arrestin-Dependent Signaling
Louis M. Luttrell et al.
PHARMACOLOGICAL REVIEWS (2010)
Human IL-8 Regulates Smooth Muscle Cell VCAM-1 Expression in Response to Endothelial Cells Exposed to Atheroprone Flow
Nicole E. Hastings et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
SB265610 is an allosteric, inverse agonist at the human CXCR2 receptor
M. E. Bradley et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Differential Activation and Regulation of CXCR1 and CXCR2 by CXCL8 Monomer and Dimer
Mohd W. Nasser et al.
JOURNAL OF IMMUNOLOGY (2009)
A Role for a CXCR2/Phosphatidylinositol 3-Kinase γ Signaling Axis in Acute and Chronic Vascular Permeability
Julie Gavard et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
Chemokines in Vascular Dysfunction and Remodeling
Andreas Schober
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
The Interleukin-8 Pathway in Cancer
David J. J. Waugh et al.
CLINICAL CANCER RESEARCH (2008)
Hepatocyte signaling through CXC chemokine receptor-2 is detrimental to liver recovery after ischemia/reperfusion in mice
Satoshi Kuboki et al.
HEPATOLOGY (2008)
Inhibition of CXCR2 attenuates bronchial angiogenesis in the ischemic rat lung
Adlah Sukkar et al.
JOURNAL OF APPLIED PHYSIOLOGY (2008)
The Carboxyl-terminal PDZ Ligand Motif of Chemokine Receptor CXCR2 Modulates Post-endocytic Sorting and Cellular Chemotaxis
Paige J. Baugher et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Structural determinants of MIF functions in CXCR2-mediated inflammatory and atherogenic leukocyte recruitment
Christian Weber et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
The effects of interleukin-8 on airway smooth muscle contraction in cystic fibrosis
Vasanthi Govindaraju et al.
RESPIRATORY RESEARCH (2008)
Transactivation of vascular endothelial growth factor receptor-2 by interleukin-8 (IL-8/CXCL8) is required for IL-8/CXCL8-induced endothelial permeability
Melissa L. Petreaca et al.
MOLECULAR BIOLOGY OF THE CELL (2007)
CXCR2 blockade impairs angiotensin II-induced CC chemokine synthesis and mononuclear leukocyte infiltration
Yafa Naim et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
A novel, orally active CXCR1/2 receptor antagonist, sch527123, inhibits neutrophil recruitment, mucus production, and goblet cell hyperplasia in animal models of pulmonary inflammation
Richard W. Chapman et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Protective effect of an inhibitor of interleukin-8 (Meraxin) from ischemia and reperfusion injury in a rat model of kidney transplantation
F. Neri et al.
TRANSPLANTATION PROCEEDINGS (2007)
Perivascular mast cells promote atherogenesis and induce plaque destabilization in apolipoprotein E-deficient mice
Ilze Bot et al.
CIRCULATION (2007)
MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment
Juergen Bernhagen et al.
NATURE MEDICINE (2007)
Importance of CXC chemokine receptor 2 in the homing of human peripheral blood endothelial progenitor cells to sites of arterial injury
Mihail Hristov et al.
CIRCULATION RESEARCH (2007)
Interleukin-8: novel roles in human airway smooth muscle cell contraction and migration
Vasanthi Govindaraju et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2006)
Species differences in the pharmacokinetics and metabolism of reparixin in rat and dog
I. Midgley et al.
XENOBIOTICA (2006)
Up-regulated expression of the CXCR2 ligand KC/GRO-α in atherosclerotic lesions plays a central role in macrophage accumulation and lesion progression
WA Boisvert et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
Transfer of endothelial progenitor and bone marrow cells influences atherosclerotic plaque size and composition in apolipoprotein E knockout mice
J George et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Cytokines and cardiovascular disease
VC Mehra et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2005)
Molecular basis of the effects of shear stress on vascular endothelial cells
YSJ Li et al.
JOURNAL OF BIOMECHANICS (2005)
Neutrophil recruitment in the reperfused-injured rat liver was effectively attenuated by repertaxin, a novel allosteric noncompetitive inhibitor of CXCL8 receptors:: A therapeutic approach for the treatment of post-ischemic hepatic syndromes
B Cavalieri et al.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2005)
Neuroprotection with the CXCL8 inhibitor repertaxin in transient brain ischemia
A Garau et al.
CYTOKINE (2005)
Inhibition of the chemokine receptor CXCR2 prevents kidney graft function deterioration due to ischemia/reperfusion
D Cugini et al.
KIDNEY INTERNATIONAL (2005)
Impaired interleukin-8-and GROα-induced phosphorylation of extracellular signal-regulated kinase result in decreased migration of neutrophils from patients with myelodysplasia
GM Fuhler et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2005)
Activation of CD38 by interleukin-8 signaling regulates intracellular Ca2+ level and motility of lymphokine-activated killer cells
SY Rah et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Repertaxin, a novel inhibitor of rat CXCR2 function, inhibits inflammatory responses that follow intestinal ischaemia and reperfusion injury
DG Souza et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
Noncompetitive allosteric inhibitors of the inflammatory chemokine receptors CXCR1 and CXCR2: Prevention of reperfusion injury
R Bertini et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Angiotensin II induces neutrophil accumulation in vivo through generation and release of CXC chemokines
YN Abu Nabah et al.
CIRCULATION (2004)
Chemokines - Key regulators of mononuclear cell recruitment in atherosclerotic vascular disease
C Weber et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
The C-terminal domain LLKIL motif of CXCR2 is required for ligand-mediated polarization of early signals during chemotaxis
JQ Sai et al.
JOURNAL OF CELL SCIENCE (2004)
Deep vein thrombosis resolution is modulated by monocyte CXCR2-mediated activity in a mouse model
PK Henke et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
Opposing effects mediated by the chemokine receptor CXCR2 on myocardial ischemia-reperfusion injury - Recruitment of potentially damaging neutrophils and direct myocardial protection
ST Tarzami et al.
CIRCULATION (2003)
Fluid shear stress and the vascular endothelium: for better and for worse
N Resnick et al.
PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY (2003)
Angiogenic effects of interleukin 8 (CXCL8) in human intestinal microvascular endothelial cells are mediated by CXCR2
J Heidemann et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Interleukin-8-induced proliferation, survival, and MMP production in CXCR1 and CXCR2 expressing human umbilical vein endothelial cells
AH Li et al.
MICROVASCULAR RESEARCH (2002)
CXCL8(3-73)K11R/G31P antagonizes ligand binding to the neutrophil CXCR1 and CXCR2 receptors and cellular responses to CXCL8/IL-8
F Li et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
Endothelial responses to mechanical stress: Where is the mechanosensor?
MH Ali et al.
CRITICAL CARE MEDICINE (2002)
Inhibition of IL-8-mediated MAPK activation in human neutrophils by β1 integrin ligands
D Xythalis et al.
INFLAMMATION (2002)
The cytoskeleton under external fluid mechanical forces: Hemodynamic forces acting on the endothelium
BP Helmke et al.
ANNALS OF BIOMEDICAL ENGINEERING (2002)
IL-8 activates endothelial cell CXCR1 and CXCR2 through Rho and Rac signaling pathways
IU Schraufstatter et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2001)
Differential expression and responsiveness of chemokine receptors (CXCR1-3) by human microvascular endothelial cells and umbilical vein endothelial cells
R Salcedo et al.
FASEB JOURNAL (2000)
Regulation of tyrosine kinase activation and granule release through β-arrestin by CXCRI
J Barlic et al.
NATURE IMMUNOLOGY (2000)
Delayed wound healing in CXCR2 knockout mice
RM Devalaraja et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2000)
分享论文
